Long-term effects of recombinant leukocyte alpha interferon in the treatment of chronic delta hepatitis.

G. Tocci; L. Antonelli; E. Boumis; M. Colaiacomo; P. Guarascio; C. Struglia; G. Tossini; G. Visco

Long-term effects of recombinant leukocyte alpha interferon in the treatment of chronic delta hepatitis.

G. Tocci, L. Antonelli, E. Boumis, M. Colaiacomo, P. Guarascio, C. Struglia, G. Tossini, G. Visco

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

Research output: Contribution to journal › Article › peer-review

Abstract

A pilot study is described, in which 25 chronic CDH patients were treated with 3 MU recombinant alpha-interferon per week for 4 months. Improvement was transient and no long-term effects were noted. Side effects were well tolerated and reversible so that longer treatment and higher dosages should be possible.

Original language	English
Pages (from-to)	306-307
Number of pages	2
Journal	Archives of virology. Supplementum
Volume	4
Publication status	Published - 1992

ASJC Scopus subject areas

Immunology and Microbiology(all)

Cite this

@article{1257622e0ac14758a495cf1efedb96cf,

title = "Long-term effects of recombinant leukocyte alpha interferon in the treatment of chronic delta hepatitis.",

abstract = "A pilot study is described, in which 25 chronic CDH patients were treated with 3 MU recombinant alpha-interferon per week for 4 months. Improvement was transient and no long-term effects were noted. Side effects were well tolerated and reversible so that longer treatment and higher dosages should be possible.",

author = "G. Tocci and L. Antonelli and E. Boumis and M. Colaiacomo and P. Guarascio and C. Struglia and G. Tossini and G. Visco",

year = "1992",

language = "English",

volume = "4",

pages = "306--307",

journal = "Archives of Virology, Supplement",

issn = "0939-1983",

publisher = "Springer Verlag",

}

TY - JOUR

T1 - Long-term effects of recombinant leukocyte alpha interferon in the treatment of chronic delta hepatitis.

AU - Tocci, G.

AU - Antonelli, L.

AU - Boumis, E.

AU - Colaiacomo, M.

AU - Guarascio, P.

AU - Struglia, C.

AU - Tossini, G.

AU - Visco, G.

PY - 1992

Y1 - 1992

N2 - A pilot study is described, in which 25 chronic CDH patients were treated with 3 MU recombinant alpha-interferon per week for 4 months. Improvement was transient and no long-term effects were noted. Side effects were well tolerated and reversible so that longer treatment and higher dosages should be possible.

AB - A pilot study is described, in which 25 chronic CDH patients were treated with 3 MU recombinant alpha-interferon per week for 4 months. Improvement was transient and no long-term effects were noted. Side effects were well tolerated and reversible so that longer treatment and higher dosages should be possible.

UR - http://www.scopus.com/inward/record.url?scp=0027017066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027017066&partnerID=8YFLogxK

M3 - Article

C2 - 1450710

AN - SCOPUS:0027017066

SN - 0939-1983

VL - 4

SP - 306

EP - 307

JO - Archives of Virology, Supplement

JF - Archives of Virology, Supplement

ER -

Long-term effects of recombinant leukocyte alpha interferon in the treatment of chronic delta hepatitis.

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this